Publicaciones en colaboración con investigadoras/es de Hospital de Cruces (30)

2023

  1. Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review

    Journal of Clinical Medicine, Vol. 12, Núm. 21

2022

  1. In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study

    Frontiers in Cellular and Infection Microbiology, Vol. 12

2021

  1. Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients

    Diagnostic Microbiology and Infectious Disease, Vol. 101, Núm. 3

2019

  1. Method-dependent epidemiological cutoff values for detection of triazole resistance in Candida and Aspergillus species for the Sensititre Yeastone colorimetric broth and etest agar diffusion methods

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 1

2018

  1. Scedosporium and Lomentospora: An updated overview of underrated opportunists

    Medical Mycology, Vol. 56, pp. S102-S125

2016

  1. Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study

    Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 732.e1-732.e8

  2. Transmission dynamics of HIV-1 subtype B in the Basque Country, Spain

    Infection, Genetics and Evolution, Vol. 40, pp. 91-97

2015

  1. Multidisciplinary approach to human papillomavirus infection

    Progresos de Obstetricia y Ginecologia

2014

  1. Gram-negative prosthetic joint infection: Outcome of a debridement, antibiotics and implant retention approach. A large multicentre study

    Clinical Microbiology and Infection, Vol. 20, Núm. 11, pp. O911-O919

2012

  1. Invasive fungal disease: Conventional or molecular mycological diagnosis?

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 30, Núm. 9, pp. 560-571

2011

  1. Evidencias científicas que respaldan el uso de micafungina en el tratamiento de la candidiasis invasora

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. SUPPL. 2, pp. 15-22

  2. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 10, pp. 2315-2322

2009

  1. Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients

    Clinical Microbiology and Infection, Vol. 15, Núm. 6, pp. 592-595

  2. HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations

    Journal of Antimicrobial Chemotherapy, Vol. 64, Núm. 2, pp. 251-258

  3. Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: Influence on mortality

    Clinical and Vaccine Immunology, Vol. 16, Núm. 10, pp. 1527-1528

2008

  1. Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre

    International Journal of Antimicrobial Agents, Vol. 31, Núm. 3, pp. 266-271

2007

  1. Advances in lower respiratory tract infections in critically ill patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 25, Núm. SUPPL. 1, pp. 47-57

  2. Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)

    Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229

2006

  1. Anticuerpos anti-micelio de Candida albicans en dos pacientes de cuidados intensivos con candidiasis invasora

    Revista Iberoamericana de Micologia, Vol. 23, Núm. 1, pp. 50-53

2005

  1. Orogenital transmission of Neisseria meningitidis serogroup C confirmed by genotyping techniques

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 24, Núm. 1, pp. 51-53